Published in Cytotherapy on January 01, 2008
A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One (2010) 3.14
Immunobiology of mesenchymal stem cells. Cell Death Differ (2013) 2.18
Fracture healing: mechanisms and interventions. Nat Rev Rheumatol (2014) 1.33
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica (2009) 1.10
Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS One (2011) 1.02
Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J Immunol Res (2015) 1.00
Innate immune system and preeclampsia. Front Immunol (2014) 0.98
Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy. J Immunol Res (2014) 0.87
Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2. Stem Cells Dev (2014) 0.82
Interactions between MSCs and immune cells: implications for bone healing. J Immunol Res (2015) 0.81
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: a role for HLA-G molecules. Haematologica (2013) 0.80
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules. Haematologica (2013) 0.78
Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients. J Immunol Res (2016) 0.76
Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Dev (2016) 0.75
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol (1997) 2.81
Mechanisms underlying FeCl3-induced arterial thrombosis. J Thromb Haemost (2011) 2.18
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int (2013) 2.00
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest (1995) 1.73
Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J (1999) 1.72
P2 purinoceptors in the immune system. Ciba Found Symp (1996) 1.68
Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia (1998) 1.67
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart (2010) 1.64
Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology (1992) 1.61
Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice. J Thromb Haemost (2010) 1.57
A revised model of platelet aggregation. J Clin Invest (2000) 1.54
Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther (2004) 1.53
Cytolytic P2X purinoceptors. Cell Death Differ (1998) 1.50
Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem (1999) 1.48
A multiparametric approach is essential to define different clinicopathological entities within pseudopelade of Brocq. Br J Dermatol (2002) 1.43
An accurate and reliable real time SNP genotyping assay for the HLA-G +3142 bp C>G polymorphism. Tissue Antigens (2012) 1.43
Differences in the chromosomal profile of AML-M0 versus AML-M1: response. Blood (1996) 1.42
High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol (2014) 1.42
The platelet glycoprotein GPIbbeta intracellular domain participates in von Willebrand factor induced-filopodia formation independently of the Ser 166 phosphorylation site. J Thromb Haemost (2009) 1.41
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. J Thromb Haemost (2005) 1.40
Is alendronate clinically gastrotoxic? Re: Graham et al. primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Am J Gastroenterol (1998) 1.40
Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood (1998) 1.36
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo. Bone Marrow Transplant (2011) 1.32
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood (1996) 1.26
CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol (1997) 1.26
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem (1996) 1.24
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol (2000) 1.23
An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa. Gastrointest Endosc (1975) 1.23
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol (2009) 1.20
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy (2008) 1.17
Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization. J Thromb Haemost (2009) 1.14
Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and Do not exhibit a Bernard-Soulier phenotype. Blood (1999) 1.14
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J Cell Biol (1994) 1.12
Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. Psychother Psychosom (2001) 1.10
Screening for binge eating disorder in obese outpatients. Compr Psychiatry (2000) 1.10
BCR-ABL rearrangement is not detectable in essential thrombocythemia. Blood (2001) 1.10
Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear. J Biol Chem (1999) 1.09
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi. Blood (2000) 1.09
Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem (1993) 1.08
The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. J Biol Chem (1999) 1.06
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review. Leukemia (2004) 1.06
CD38: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res (1992) 1.06
Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood (1999) 1.05
Giant cell tumor of bone: a model for the in vitro human osteoclast characterization. Tumori (1989) 1.05
Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy (2005) 1.05
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study. Bone Marrow Transplant (2009) 1.05
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. Endocr Relat Cancer (2005) 1.04
Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry (2000) 1.03
Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol (2009) 1.03
Clinical and biological significance of CD34 expression in acute leukemia. J Biol Regul Homeost Agents (2001) 1.03
Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol (2001) 1.02
Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR). Br J Haematol (1998) 1.02
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation. Br J Haematol (1996) 1.01
Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med (2004) 1.01
Eating disorders in patients with type 1 diabetes: a meta-analysis. J Endocrinol Invest (2005) 1.01
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens (2008) 1.01
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy (2000) 1.01
Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1996) 1.01
Osteogenic and chondrogenic differentiation: comparison of human and rat bone marrow mesenchymal stem cells cultured into polymeric scaffolds. Eur J Histochem (2007) 1.00
Eating behavior in obese patients with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord (2002) 0.99
Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod (2004) 0.99
A prospective survey of febrile events in hematological malignancies. Ann Hematol (2011) 0.99
Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS (1997) 0.97
Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. Leukemia (2012) 0.97
Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol (1992) 0.97
Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms? J Clin Lab Immunol (1987) 0.97
Psychometric properties of EDE 12.0D in obese adult patients without binge eating disorder. Eat Weight Disord (1997) 0.96
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. J Leukoc Biol (1996) 0.96
Angiogenic potential of human dental pulp stromal (stem) cells. Int J Immunopathol Pharmacol (2009) 0.95
Different patterns of restriction to B19 parvovirus replication in human blast cell lines. Virology (2000) 0.95
Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. J Invest Dermatol (1992) 0.95
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem (1999) 0.94
The alpha(IIb)beta(3) integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34(+) cord blood cells to megakaryocytes. Blood (2000) 0.94
Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood (2001) 0.94
Diamond-Blackfan anemia: report of seven further mutations in the RPS19 gene and evidence of mutation heterogeneity in the Italian population. Blood Cells Mol Dis (2000) 0.94
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol (1998) 0.93
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler (2006) 0.93
Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von willebrand factor interaction. Blood (2000) 0.93